Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-29T00:46:23.516Z Has data issue: false hasContentIssue false
  • English
  • Français

Long-Term Survival of a Patient with Glioblastoma

Published online by Cambridge University Press:  02 December 2014

Adrian Sacher ,
Robert Wollmann ,
Urmi Kalokhe ,
David Munoz ,
Marie-Christine Guiot  and
R. Loch Macdonald
Adrian Sacher
Affiliation:
Division of Neurosurgery, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Department of Surgery, University of Toronto, Toronto, Ontario, Canada
Robert Wollmann
Affiliation:
Department of Pathology, University of Chicago Medical Center and the Pritzker School of Medicine, Chicago, Illinois, USA
Urmi Kalokhe
Affiliation:
St. Margaret Mercy Hospital, Hammond, Indiana, USA
David Munoz
Affiliation:
Division of Pathology, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Department of Surgery, University of Toronto, Toronto, Ontario, Canada
Marie-Christine Guiot
Affiliation:
Department of Pathology, McGill University, Montreal, Quebec, Canada
R. Loch Macdonald*
Affiliation:
Division of Neurosurgery, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Department of Surgery, University of Toronto, Toronto, Ontario, Canada
*
Division of Neurosurgery, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario, M5B 1W8, Canada.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Information
Canadian Journal of Neurological Sciences , Volume 37 , Issue 2 , March 2010 , pp. 289 - 292
Copyright
Copyright © The Canadian Journal of Neurological 2010

References

1. Filippini, G, Falcone, C, Boiardi, A, Broggi, G, Bruzzone, MG, Caldiroli, D, et al. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol. 2008;10:79–87.Google Scholar
2. Hegi, ME, Diserens, AC, Gorlia, T, Hamou, MF, de, TN, Weller, M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997–1003.CrossRefGoogle ScholarPubMed
3. Stupp, R, Mason, WP, van den Bent, MJ, Weller, M, Fisher, B, Taphoorn, MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.Google Scholar
4. van den Bent, MJ, Hegi, ME, Stupp, R. Recent developments in the use of chemotherapy in brain tumours. Eur J Cancer. 2006;42:582–8.Google Scholar
5. Scott, JN, Rewcastle, NB, Brasher, PM, Fulton, D, Hagen, NA, MacKinnon, JA, et al. Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci. 1998;25:197–201.Google Scholar
6. Scott, JN, Rewcastle, NB, Brasher, PM, Fulton, D, MacKinnon, JA, Hamilton, M, et al. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol. 1999;46:183–8.Google Scholar
7. Krex, D, Klink, B, Hartmann, C, von, DA, Pietsch, T, Simon, M, et al. Long-term survival with glioblastoma multiforme. Brain. 2007;130:2596–606.CrossRefGoogle ScholarPubMed
8. Houillier, C, Lejeune, J, Ouaich-Amiel, A, Laigle-Donadey, F, Criniere, E, Mokhtari, K, et al. Prognostic impact of molecular markers in a series of 220 primary glioblastomas. Cancer. 2006;106:2218–23.Google Scholar
9. Shinojima, N, Kochi, M, Hamada, J, Nakamura, H, Yano, S, Makino, K, et al. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme. J Neurosurg. 2004;101:219–26.Google Scholar
10. Miller, CR, Perry, A. Glioblastoma. Arch Pathol Lab Med. 2007;131:397–406.Google Scholar
11. Burton, EC, Lamborn, KR, Feuerstein, BG, Prados, M, Scott, J, Forsyth, P, et al. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res. 2002;62:6205–10.Google Scholar
12. Burton, EC, Lamborn, KR, Forsyth, P, Scott, J, O’Campo, J, Uyehara-Lock, J, et al. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res. 2002;8:180–7.Google Scholar
13. Schmidt, MC, Antweiler, S, Urban, N, Mueller, W, Kuklik, A, Meyer-Puttlitz, B, et al. Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol. 2002;61:321–8.CrossRefGoogle ScholarPubMed
14. Dehdashti, AR, Sharma, S, Laperriere, N, Bernstein, M. Coincidence vs cause: cure in three glioblastoma patients treated with brachytherapy. Can J Neurol Sci. 2007;34:339–42.CrossRefGoogle ScholarPubMed
15. Bucy, PC, Oberhill, HR, Siqueira, EB, Zimmerman, HM, Jelsma, RK. Cerebral glioblastomas can be cured! Neurosurgery. 1985;16:714–7.Google Scholar
16. Burzynski, SR, Lewy, RI, Weaver, R, Janicki, T, Jurida, G, Khan, M, et al. Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme. Integr Cancer Ther. 2004;3:257–61.CrossRefGoogle ScholarPubMed
17. Cankovic, M, Mikkelsen, T, Rosenblum, ML, Zarbo, RJ. A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue. Lab Invest. 2007;87:392–7.CrossRefGoogle ScholarPubMed
18. Ito, M, Wakabayashi, T, Natsume, A, Hatano, H, Fujii, M, Yoshida, J. Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: case report. Neurosurgery. 2007;61:E168–9.Google Scholar
19. Kouwenhoven, MC, Kros, JM, French, PJ, Biemond-ter Stege, EM, Graveland, WJ, Taphoorn, MJ, et al. 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. Eur J Cancer. 2006;42:2499–503.Google Scholar
20. Cairncross, G, Berkey, B, Shaw, E, Jenkins, R, Scheithauer, B, Brachman, D, et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol. 2006;24:2707–14.Google Scholar
21. Bauman, GS, Ino, Y, Ueki, K, Zlatescu, MC, Fisher, BJ, Macdonald, DR, et al. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys. 2000;48:825–30.Google Scholar
22. Smith, JS, Perry, A, Borell, TJ, Lee, HK, O’Fallon, J, Hosek, SM, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol. 2000;18:636–45.Google Scholar
23. Brat, DJ, Seiferheld, WF, Perry, A, Hammond, EH, Murray, KJ, Schulsinger, AR, et al. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials. Neuro Oncol. 2004;6:96–103.Google Scholar
24. Nagasaka, T, Gunji, M, Hosokai, N, Hayashi, K, Ikeda, H, Ito, M, et al. FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma. Brain Tumor Pathol. 2007;24:1–5.CrossRefGoogle ScholarPubMed
25. Boulay, JL, Miserez, AR, Zweifel, C, Sivasankaran, B, Kana, V, Ghaffari, A, et al. Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors. PLoS ONE. 2007;2:e576.Google Scholar
26. Nakagawa, T, Ido, K, Sakuma, T, Takeuchi, H, Sato, K, Kubota, T. Prognostic significance of the immunohistochemical expression of O-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas. Neuropathology. 2008;29:379–88.Google Scholar
27. Mattos, JP, Marenco, HA, Campos, JM, Faria, AV, Queiroz, LS, Borges, G, et al. Cerebellar glioblastoma multiforme in an adult. Arq Neuropsiquiatr. 2006;64:132–5.CrossRefGoogle ScholarPubMed
28. Kopelson, G. Cerebellar glioblastoma. Cancer. 1982;50:308–11.Google Scholar
29. Chamberlain, MC, Silver, P, Levin, VA. Poorly differentiated gliomas of the cerebellum. A study of 18 patients. Cancer. 1990;65:337–40.Google Scholar